Charles W. Newhall III, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 10,700 shares at $36.24 ($388K) on 2024-11-11, disclosed to the SEC on 2024-11-12.
Open-market sale of $388k SUPN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SUPN | SELL | 2025-08-27 | $45K | — | Filing → |
| SUPN | SELL | 2025-08-26 | $64K | — | Filing → |
| SUPN | SELL | 2023-11-20 | $70K | — | Filing → |